Treatment responses with once-weekly teriparatide therapy for osteoporosis

被引：0
|
作者：
M. Shiraki
S. Ueda
T. Sugimoto
T. Kuroda
T. Nakamura
机构：
[1] Research Institute and Practice for Involutional Diseases,Department of Internal Medicine
[2] Asahi Kasei Pharma Corporation,Medical Affairs Department
[3] Shimane University Faculty of Medicine,Internal Medicine 1
[4] National Center for Global Health and Medicine,undefined
来源：
Osteoporosis International | 2016年 / 27卷
关键词：
Bone mineral density; Incident fracture; Teriparatide; Treatment success;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3057 / 3062
页数：5
相关论文
共 50 条
  • [31] Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
    Sugimoto, T.
    Nakamura, T.
    Nakamura, Y.
    Isogai, Y.
    Shiraki, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 (03) : 1173 - 1180
  • [32] Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
    T. Sugimoto
    T. Nakamura
    Y. Nakamura
    Y. Isogai
    M. Shiraki
    [J]. Osteoporosis International, 2014, 25 : 1173 - 1180
  • [33] Acute polyarthritis related to once-weekly alendronate in a woman with osteoporosis
    Gerster, JC
    [J]. JOURNAL OF RHEUMATOLOGY, 2004, 31 (04) : 829 - 830
  • [34] Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: A randomized double-blind study
    Rosen, CJ
    Hochberg, MC
    Bonnick, SL
    McClung, M
    Miller, P
    Broy, S
    Kagan, R
    Chen, E
    Petruschke, RA
    Thompson, DE
    de Papp, AE
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (01) : 141 - 151
  • [35] Once-weekly teriparatide reduces serum sclerostin levels in postmenopausal women with osteoprosis
    Ikeda, Terumasa
    Kaji, Hiroshi
    Tamura, Yukinori
    Akagi, Masao
    [J]. JOURNAL OF ORTHOPAEDIC SCIENCE, 2019, 24 (03) : 532 - 538
  • [36] The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT
    Ito, M.
    Oishi, R.
    Fukunaga, M.
    Sone, T.
    Sugimoto, T.
    Shiraki, M.
    Nishizawa, Y.
    Nakamura, T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 (03) : 1163 - 1172
  • [37] TREATMENT WITH ONCE-WEEKLY ALENDRONATE 70 MG COMPARED TO ONCE-WEEKLY RISEDRONATE 35 MG IN WOMEN WITH POSTMENOPAUSALE OSTEOPOROSIS: A RANDOMIZED DOUBLE-BLIND STUDY
    Pietschmann, Peter
    [J]. JOURNAL FUR MINERALSTOFFWECHSEL, 2005, 12 (01): : 36 - 38
  • [38] The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT
    M. Ito
    R. Oishi
    M. Fukunaga
    T. Sone
    T. Sugimoto
    M. Shiraki
    Y. Nishizawa
    T. Nakamura
    [J]. Osteoporosis International, 2014, 25 : 1163 - 1172
  • [39] Advances in Diabetes Treatment - Once-Weekly Insulin
    Gottlieb, Peter A.
    Michels, Aaron W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (22): : 2171 - 2172
  • [40] Once-weekly fluconazole in the treatment of onychomycosis: Introduction
    Elewski, BE
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (06) : S73 - S76
12345